Lv2
108 积分 2022-11-27 加入
Safety and Efficacy of Intensive BP Control in Cardiovascular-Kidney-Metabolic Syndrome
1个月前
已完结
Residual cholesterol and inflammatory risk in statin-treated patients undergoing percutaneous coronary intervention
5个月前
已完结
High‐sensitivity C‐reactive protein to high‐density lipoprotein cholesterol ratio predicts long‐term adverse outcomes in patients who underwent percutaneous coronary intervention: A prospective cohort study
6个月前
已完结
[Association between plasma HDL-C levels and coronary artery severity and impact on outcomes of patients underwent percutaneous coronary intervention]
7个月前
已完结
Lipoprotein(a), Cholesterol, Triglyceride Levels, and Vulnerable Coronary Plaques
8个月前
已完结
Association Between Lipoprotein(a) and Obstructive Coronary Artery Disease and High-Risk Plaque: Insights From the PROMISE Trial
8个月前
已完结
Lipoprotein(A) is associated with long-term plaque progression on serial coronary CT angiography
8个月前
已关闭
Lipoprotein(a) is an important factor to determine coronary artery plaque morphology in patients with acute myocardial infarction
8个月前
已完结
Lipoprotein(a), Cholesterol, Triglyceride Levels, and Vulnerable Coronary Plaques
8个月前
已完结
High-sensitivity C-reactive protein, plaque vulnerability and adverse events in patients with stable coronary disease: An optical coherence tomography study
9个月前
已完结
皖公网安备34019202002308
